
Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings
Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2013年第一次临时股东大会的公告 | 2013-02-06 | Chinese | |
| 第五届董事会第十四次会议决议公告 | 2013-02-06 | Chinese | |
| 关于2012年年度利润分配预案的预披露公告 | 2013-02-04 | Chinese | |
| 2012年年度业绩快报 | 2013-02-04 | Chinese | |
| 关于横店制剂园区项目建设的公告 | 2013-01-30 | Chinese | |
| 第五届董事会第十三次会议决议公告 | 2013-01-30 | Chinese |
Browse filings by year
27 years- 2026 59 filings
- 2025 128 filings
- 2024 92 filings
- 2023 80 filings
- 2022 119 filings
- 2021 70 filings
- 2020 103 filings
- 2019 86 filings
- 2018 58 filings
- 2017 101 filings
- 2016 81 filings
- 2015 125 filings
- 2014 95 filings
- 2013 119 filings
- 2012 85 filings
- 2011 63 filings
- 2010 40 filings
- 2009 30 filings
- 2008 48 filings
- 2007 59 filings
- 2006 40 filings
- 2005 43 filings
- 2004 34 filings
- 2003 47 filings
- 2002 30 filings
- 2001 6 filings
- 1997 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2013
15 filings
| |||||
| 43423897 | 关于召开2013年第一次临时股东大会的公告 | 2013-02-06 | Chinese | ||
| 43423868 | 第五届董事会第十四次会议决议公告 | 2013-02-06 | Chinese | ||
| 43423841 | 关于2012年年度利润分配预案的预披露公告 | 2013-02-04 | Chinese | ||
| 43423809 | 2012年年度业绩快报 | 2013-02-04 | Chinese | ||
| 43423757 | 关于横店制剂园区项目建设的公告 | 2013-01-30 | Chinese | ||
| 43423722 | 第五届董事会第十三次会议决议公告 | 2013-01-30 | Chinese | ||
| 43423696 | 第五届董事会第十二次会议决议公告 | 2013-01-29 | Chinese | ||
| 43423671 | 关于控股子公司浙江普洛得邦制药有限公司7-AVNA项目投资的公告 | 2013-01-29 | Chinese | ||
| 43423576 | 第五届监事会第九次会议决议公告 | 2013-01-29 | Chinese | ||
| 43423481 | 浙江横店进出口有限公司与医药业务相关的经营性资产2010年至2012年1-6月模拟财务报表审计报告 | 2013-01-07 | Chinese | ||
| 43422228 | 浙江普洛康裕医药药材有限公司2010年至2012年1-6月财务报表审计报告 | 2013-01-07 | Chinese | ||
| 43420948 | 关于上市公司股东、关联方及上市公司承诺履行情况的公告 | 2013-01-07 | Chinese | ||
| 43420895 | 中国银河证券股份有限公司关于横店集团控股有限公司收购公司之财务顾问报告 | 2013-01-07 | Chinese | ||
| 43420724 | 2010年至2012年1-6月备考财务报表审计报告 | 2013-01-07 | Chinese | ||
| 43418081 | 西南证券股份有限公司关于公司非公开发行股份购买资产并募集配套资金暨关联交易实施情况之独立财务顾问核查意见 | 2013-01-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Apeloa Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53793/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53793 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53793 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53793 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53793}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Apeloa Pharmaceutical Co.,Ltd. (id: 53793)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.